365 related articles for article (PubMed ID: 30144445)
41. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.
Tu Z; Xu B; Qu C; Tao Y; Chen C; Hua W; Feng G; Chang H; Liu Z; Li G; Jiang C; Yi W; Zeng M; Xia Y
Radiat Oncol; 2015 May; 10():123. PubMed ID: 26024915
[TBL] [Abstract][Full Text] [Related]
42. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
43. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
[No Abstract] [Full Text] [Related]
44. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
45. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
46. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
[TBL] [Abstract][Full Text] [Related]
47. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
Kang M; Xiao J; Wang J; Zhou P; Wei T; Zhao T; Wang R
Cancer Med; 2016 Jun; 5(6):1163-73. PubMed ID: 26922862
[TBL] [Abstract][Full Text] [Related]
48. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
49. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
[TBL] [Abstract][Full Text] [Related]
50. SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.
Pan X; Mou J; Liu S; Sun Z; Meng R; Zhou Z; Wu G; Peng G
Oncol Rep; 2015 Jun; 33(6):2999-3005. PubMed ID: 25962492
[TBL] [Abstract][Full Text] [Related]
51. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
[TBL] [Abstract][Full Text] [Related]
52. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
[TBL] [Abstract][Full Text] [Related]
54. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway.
Li H; Chen X; Yu Y; Wang Z; Zuo Y; Li S; Yang D; Hu S; Xiang M; Xu Z; Yu Z
Oncol Rep; 2014 Dec; 32(6):2596-604. PubMed ID: 25333332
[TBL] [Abstract][Full Text] [Related]
55. Slug mediates nasopharyngeal carcinoma radioresistance via downregulation of PUMA in a p53-dependent and -independent manner.
Xu T; Fan B; Lv C; Xiao D
Oncol Rep; 2015 May; 33(5):2631-8. PubMed ID: 25812964
[TBL] [Abstract][Full Text] [Related]
56. RPA1 expression in esophageal carcinoma and its influence on radiosensitivity of esophageal carcinoma TE-1 cells.
Zhang DJ; Xiang J; Wang X; Wang J; Xiao JC; Xu W; Xu H; Xin Y; Zhang LZ; Pei DS; Zheng JN; Gu YM
Panminerva Med; 2015 Dec; 57(4):183-9. PubMed ID: 26824734
[TBL] [Abstract][Full Text] [Related]
57. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
[TBL] [Abstract][Full Text] [Related]
59. Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.
Gressette M; Vérillaud B; Jimenez-Pailhès AS; Lelièvre H; Lo KW; Ferrand FR; Gattolliat CH; Jacquet-Bescond A; Kraus-Berthier L; Depil S; Busson P
PLoS One; 2014; 9(3):e91325. PubMed ID: 24618637
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
